» Articles » PMID: 30373372

Early Risk Factors for Daily Cannabis Use in Young Adults

Overview
Specialty Psychiatry
Date 2018 Oct 31
PMID 30373372
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Daily cannabis use can portend problematic use or dependence. We aimed to identify early risk factors for daily cannabis use in young adults.

Methods: Data were available in a longitudinal investigation of 1294 grade 7 students age 12 to 13 years at inception recruited in 10 secondary schools in Montreal, Canada, in 1999. Data on daily cannabis use were collected in mailed self-report questionnaires from 878 participants (67.9% of 1294) at age 20. The associations between each of 23 potential risk factors measured in grade 7 and daily cannabis use at age 20 were modeled using logistic regression.

Results: At age 20, 44% of participants reported past-year cannabis use; 10% reported daily use. Older age; male sex; higher levels of family stress and other stress; use of alcohol, cigarettes, and other tobacco products; parent(s), sibling(s), and friend(s) smoke cigarettes; higher body mass index; higher impulsivity and novelty seeking; and lower self-esteem increased the odds of daily cannabis use.

Conclusions: Children at risk of daily cannabis use as young adults can be identified early. They may benefit from early intervention to prevent problematic cannabis use.

Citing Articles

Efficacy of cannabinoids compared to the current standard treatments on symptom relief in persons with multiple sclerosis (CANSEP trial): study protocol for a randomized clinical trial.

Zertal A, Alami Marrouni K, Arbour N, Jutras-Aswad D, Pomey M, Rouleau I Front Neurol. 2024; 15:1440678.

PMID: 39114536 PMC: 11303178. DOI: 10.3389/fneur.2024.1440678.


Association of semaglutide with reduced incidence and relapse of cannabis use disorder in real-world populations: a retrospective cohort study.

Wang W, Volkow N, Berger N, Davis P, Kaelber D, Xu R Mol Psychiatry. 2024; 29(8):2587-2598.

PMID: 38486046 PMC: 11412894. DOI: 10.1038/s41380-024-02498-5.


[Impact of the COVID-19 pandemic on cannabis use in young adults and general population: a systematic review].

Botella-Juan L, Fernandez-Suarez N, Marcos-Delgado A, Molina-de la Torre A, Fernandez-Villa T Rev Esp Salud Publica. 2023; 97.

PMID: 38087956 PMC: 11571766.


Epidemiology and factors associated with cannabis use among patients with glaucoma in the Research Program.

Wu J, Radha Saseendrakumar B, Moghimi S, Sidhu S, Kamalipour A, Weinreb R Heliyon. 2023; 9(5):e15811.

PMID: 37215923 PMC: 10192773. DOI: 10.1016/j.heliyon.2023.e15811.


Attention deficit hyperactivity disorder symptoms and cannabis use after one year among students of the i-Share cohort.

Jean F, Arsandaux J, Montagni I, Collet O, Fatseas M, Auriacombe M Eur Psychiatry. 2022; :1-18.

PMID: 35348052 PMC: 9058443. DOI: 10.1192/j.eurpsy.2022.14.


References
1.
Wills T, Sandy J, Shinar O . Cloninger's constructs related to substance use level and problems in late adolescence: a mediational model based on self-control and coping motives. Exp Clin Psychopharmacol. 1999; 7(2):122-34. DOI: 10.1037//1064-1297.7.2.122. View

2.
Bender R, Lange S . Adjusting for multiple testing--when and how?. J Clin Epidemiol. 2001; 54(4):343-9. DOI: 10.1016/s0895-4356(00)00314-0. View

3.
Trzesniewski K, Donnellan M, Robins R . Stability of self-esteem across the life span. J Pers Soc Psychol. 2003; 84(1):205-20. View

4.
Acton G . Measurement of impulsivity in a hierarchical model of personality traits: implications for substance use. Subst Use Misuse. 2003; 38(1):67-83. DOI: 10.1081/ja-120016566. View

5.
Degenhardt L, Hall W, Lynskey M . Exploring the association between cannabis use and depression. Addiction. 2003; 98(11):1493-504. DOI: 10.1046/j.1360-0443.2003.00437.x. View